Related content

In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

By Prats G.   Roig C.   Miró E.   Navarro F.   Mirelis B.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 5, 2004-05 ,pp. : 422-422

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

By Prats G.   Roig C.   Miró E.   Navarro F.   Mirelis B.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 21, Iss. 4, 2002-04 ,pp. : 328-334

Springer Publishing Company

Access to resources Recommend Favorite

Integron-associated antimicrobial resistance in isolates of members of Enterobacteriaceae causing community-acquired urinary infections

By Dakic Ivana   Lilakos Dinos   Svabic-Vlahovic Milena   Christofilopoulou Sofia   Poggas Nikos   Charvalos Ekatherina  

Microbial Ecology in Health and Disease, Vol. 19, Iss. 3, 2007-01 ,pp. : 201-206

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics

By Colodner R.   Nuri Y.   Chazan B.   Raz R.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Iss. 4, 2008-04 ,pp. : 301-305

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens

By Hoeffken G.   Talan D.   Larsen L.   Peloquin S.   Choudhri S.   Haverstock D.   Jackson P.   Church D.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 10, 2004-10 ,pp. : 772-775

Springer Publishing Company

Access to resources Recommend Favorite